54 related articles for article (PubMed ID: 12074407)
1. p53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma.
Rodríguez-Alonso A; Pita-Fernández S; González-Carreró J; Nogueira-March JL
Eur Urol; 2002 Feb; 41(2):182-8; discussion 188-9. PubMed ID: 12074407
[TBL] [Abstract][Full Text] [Related]
2. Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks.
Bol MG; Baak JP; van Diermen B; Buhr-Wildhagen S; Janssen EA; Kjellevold KH; Kruse AJ; Mestad O; Øgreid P
J Clin Pathol; 2003 Jun; 56(6):447-52. PubMed ID: 12783972
[TBL] [Abstract][Full Text] [Related]
3. Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting prognosis of non-muscle invasive papillary urothelial carcinomas.
Kvikstad V; Lillesand M; Gudlaugsson E; Mangrud OM; Rewcastle E; Skaland I; Baak JPA; Janssen EAM
PLoS One; 2024; 19(1):e0297141. PubMed ID: 38277354
[TBL] [Abstract][Full Text] [Related]
4. The prognostic effect of immunohistochemical staining rates in patients with non-muscle-invasive bladder cancer.
Demirci A; Ordu M
Indian J Pathol Microbiol; 2023; 66(3):502-510. PubMed ID: 37530330
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Analysis of p53, CD10 and Ki67 Expression as Prognostic Biomarkers in Urinary Bladder Carcinomas Correlating with Age, Histomorphology, Grade and Stage: An Institutional Study of One and Half Year.
Mohapatra AS; Mohanty P; Pradhan S; Sabat DK
J Microsc Ultrastruct; 2023; 11(4):206-213. PubMed ID: 38213648
[TBL] [Abstract][Full Text] [Related]
6. Multi-level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients.
Tobin NP; Lindström LS; Carlson JW; Bjöhle J; Bergh J; Wennmalm K
Mol Oncol; 2014 May; 8(3):741-52. PubMed ID: 24630985
[TBL] [Abstract][Full Text] [Related]
7. Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer.
Yan X; Chen M; Xiao C; Fu J; Sun X; Hu Z; Zhou H
Ann Med; 2021 Dec; 53(1):1048-1058. PubMed ID: 34187252
[No Abstract] [Full Text] [Related]
8. Risk assessment of cancer patients based on HLA-I alleles, neobinders and expression of cytokines.
Dhall A; Patiyal S; Kaur H; Raghava GPS
Comput Biol Med; 2023 Dec; 167():107594. PubMed ID: 37918263
[TBL] [Abstract][Full Text] [Related]
9. Clinico-Pathological Features and Immunohistochemical Comparison of p16, p53, and Ki-67 Expression in Muscle-Invasive and Non-Muscle-Invasive Conventional Urothelial Bladder Carcinoma.
Hasan A; Mohammed Y; Basiony M; Hanbazazh M; Samman A; Abdelaleem MF; Nasr M; Abozeid H; Mohamed HI; Faisal M; Mohamed E; Ashmawy D; Tharwat M; Morsi DF; Farag AS; Ahmed EM; Aly NM; Abdel-Hamied HE; Salama DEA; Mandour E
Clin Pract; 2023 Jul; 13(4):806-819. PubMed ID: 37489422
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the postoperative prognosis in patients with non-muscle-invasive bladder cancer based on preoperative serum surface-enhanced Raman spectroscopy.
Zhu R; Jiang Y; Zhou Z; Zhu S; Zhang Z; Chen Z; Chen S; Zhang Z
Biomed Opt Express; 2022 Aug; 13(8):4204-4221. PubMed ID: 36032588
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin.
Yan F; Shi F; Li X; Chang H; Jin M; Li Y
J Int Med Res; 2021 Jun; 49(6):3000605211022297. PubMed ID: 34187207
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 predicts disease progression in non-muscle invasive bladder cancer.
Rinaldetti S; Wirtz R; Worst TS; Hartmann A; Breyer J; Dyrskjot L; Erben P
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1701-1709. PubMed ID: 29959570
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of ki67 in BCG-treated non-muscle invasive bladder cancer: a meta-analysis and systematic review.
He Y; Wang N; Zhou X; Wang J; Ding Z; Chen X; Deng Y
BMJ Open; 2018 Apr; 8(4):e019635. PubMed ID: 29666128
[TBL] [Abstract][Full Text] [Related]
14. Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder.
Vetterlein MW; Roschinski J; Gild P; Marks P; Soave A; Doh O; Isbarn H; Höppner W; Wagner W; Shariat SF; Brausi M; Büscheck F; Sauter G; Fisch M; Rink M
Transl Androl Urol; 2017 Dec; 6(6):1018-1026. PubMed ID: 29354488
[TBL] [Abstract][Full Text] [Related]
15. ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC).
Breyer J; Wirtz RM; Laible M; Schlombs K; Erben P; Kriegmair MC; Stoehr R; Eidt S; Denzinger S; Burger M; Hartmann A; Otto W
Virchows Arch; 2016 Nov; 469(5):547-552. PubMed ID: 27514658
[TBL] [Abstract][Full Text] [Related]
16. Role of morphometry and proliferative parameters in grading of urothelial neoplasms.
Sangwan M; Singh S; Kumar S; Chabbra S; Sen R; Rana P; Malik S; Singh S; Lamba R
Cent European J Urol; 2015; 68(1):37-44. PubMed ID: 25914836
[TBL] [Abstract][Full Text] [Related]
17. Cripto-1 expression and its prognostic value in human bladder cancer patients.
Wei B; Jin W; Ruan J; Xu Z; Zhou Y; Liang J; Cheng H; Jin K; Huang X; Lu P; Hu Q
Tumour Biol; 2015 Feb; 36(2):1105-13. PubMed ID: 25326807
[TBL] [Abstract][Full Text] [Related]
18. Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin.
Alkhateeb SS; Neill M; Bar-Moshe S; Rhijn BV; Kakiashvili DM; Fleshner N; Jewett M; Petein M; Schulman C; Hanna S; Bostrom PJ; Roumeguere T; Shariat SF; Rorive S; Zlotta AR
Urol Ann; 2011 Sep; 3(3):119-26. PubMed ID: 21976923
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of rat liver toxicity and carcinogenesis by Spirulina.
Ismail MF; Ali DA; Fernando A; Abdraboh ME; Gaur RL; Ibrahim WM; Raj MH; Ouhtit A
Int J Biol Sci; 2009 Jun; 5(4):377-87. PubMed ID: 19521547
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of relationship between HIF-1alpha immunoreactivity and stage, grade, angiogenic profile and proliferative index in bladder urothelial carcinomas.
Deniz H; Karakök M; Yagci F; Güldür ME
Int Urol Nephrol; 2010 Mar; 42(1):103-7. PubMed ID: 19484376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
